The Prognostic Value of 18F-FDG PET/CT Taken Immediately After Completion of Radiotherapy for Lung Cancer Treated with Concurrent Chemoradiotherapy: A Pilot Study

The Prognostic Value of 18F-FDG PET/CT Taken Immediately After Completion of Radiotherapy for Lung Cancer Treated with Concurrent Chemoradiotherapy: A Pilot Study - PET/CT immediately following Lung CCRT

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000037493

Enrollment

Registered

2019-09-01

Start date

2012-02-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Lung cancer

Interventions

Taking PET/CT within 24hours of completion of radiotherapy which is usually done later than 2month after completion of radiotherapy.

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: (1) Have a primary lung cancer diagnosis based on histology (2) Are planned to receive curative-intent concurrent chemoradiotherapy treatment; (3) Have provided consent of being discharged on the last day of RT to take PET/CT within 24 hours.

Exclusion criteria

Exclusion criteria: Patients who have a history of radiotherapy to the chest Patients with recurrent lung cancer.

Design outcomes

Primary

Measure	Time frame
To compare the SUVmax of PET/CT taken within 24hours of completing radiotherapy and PET/CT taken 2-9 month after completing radiotherapy and assessing the efficacy of PET/CT taken immediately after completion of radiotherapy.	—

Countries

Japan

Contacts

Public ContactAnneyuko Saito

Juntendo University Faculty of Medicine Department of Radiation Oncology

anyusaike@yahoo.co.jp047-353-3111

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026